SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-000849
Filing Date
2021-02-09
Accepted
2021-02-09 07:00:32
Documents
66
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_020921p.htm 10-Q 757981
2 EXHIBIT 31.1 exh_311.htm EX-31.1 7313
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7230
4 EXHIBIT 32.1 exh_321.htm EX-32.1 4685
5 EXHIBIT 32.2 exh_322.htm EX-32.2 4809
  Complete submission text file 0001171843-21-000849.txt   3991135

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE acst-20201231.xml EX-101.INS 739236
7 XBRL SCHEMA FILE acst-20201231.xsd EX-101.SCH 51233
8 XBRL CALCULATION FILE acst-20201231_cal.xml EX-101.CAL 35094
9 XBRL DEFINITION FILE acst-20201231_def.xml EX-101.DEF 316893
10 XBRL LABEL FILE acst-20201231_lab.xml EX-101.LAB 256305
11 XBRL PRESENTATION FILE acst-20201231_pre.xml EX-101.PRE 341210
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 21603899
SIC: 2834 Pharmaceutical Preparations